Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FZZX9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,326
Award facts
- Contract value 100% obligated
- $23,325.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units) with a ceiling value of $23,325.86. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen supplies critical medications and medical commodities to federal healthcare systems including the Defense Health Agency, U.S. Coast Guard, and other government entities. Entresto, a combination cardiac medication, falls within the company's extensive portfolio of brand-name pharmaceuticals covering multiple therapeutic domains. The firm fixed-price structure and rapid completion timeline reflect the mission-critical nature of pharmaceutical supply to military and veteran healthcare operations, with AmerisourceBergen positioned as a primary vendor supporting federal medical supply chain requirements across multiple regions and service branches.
Quick answers
Who was awarded contract SPE2DB25FZZX9?
SPE2DB25FZZX9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FZZX9 worth?
The government has obligated $23,326 on SPE2DB25FZZX9.
Is contract SPE2DB25FZZX9 an order under another contract?
Yes. SPE2DB25FZZX9 is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB25FZZX9 competed?
The extent of competition for SPE2DB25FZZX9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award